Total savings following use of anidulafungin as an alternative for other antifungal drugs
| Drug | Total doses administered detected by management software | Substitutability index | Substitutable doses | Differential saving for daily administration | Total saving |
|---|---|---|---|---|---|
| Caspofungin | 231.00 (NDC) | 79.43% (ISAC) | 183.47 | €54.96 (ΔCCCA) | €10 083.71 |
| Liposomal amphotericin B | 228.14 (NDF) | 40.95% (ISAF) | 93.43 | €291.31 (ΔCFCA) | €27 216.29 |
| TOTAL | €37 300.00 | ||||